Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

New analgesic drug candidate emerges from BioChem Pharma/Astra collaboration

Jan. 8, 1997

Dexketoprofen trometamol: An NSAID with improved safety and efficacy

Jan. 8, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

ImmuLogic files U.S. IND application for MS therapeutic

Jan. 7, 1997

First launch for Sumitomo antidepressant

Jan. 7, 1997

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Jan. 7, 1997

Cephalon files first NDA submission

Jan. 3, 1997

Cambridge NeuroScience/Gladstone Institute AD collaboration

Jan. 3, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...